Expression of ICAM-1 and VCAM-1 in renal allograft rejection

By Jeong H.J.   Lee H.H.   Kim Y.S.   Kim S.I.   Moon J.I.   Park K.  

Transplantation Proceedings, Vol. 30, Iss. 7, 1998-11 ,pp. : 2953-2954

Elsevier

Access to resources Recommend Favorite

Phosphorothioate/methoxyethyl-modified ICAM-1 antisense oligonucleotides improves prevention of ischemic/reperfusion injury 1

By Stepkowski S.M.   Chen W.   Bennett C.F.   Condon T.P.   Stecker K.   Tian L.   Kahan B.D.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3705-3706

Elsevier

Access to resources Recommend Favorite

Prevention of renal ischemic reperfusion injury using FTY 720 and ICAM-1 antisense oligonucleotides

By Ortiz A.M.   Troncoso P.   Kahan B.D.  

Transplantation Proceedings, Vol. 35, Iss. 4, 2003-06 ,pp. : 1571-1574

Elsevier

Access to resources Recommend Favorite

Antisense Cdk2 Kinase Oligodeoxynucleotide Inhibits ICAM-1 Expression in Murine Cardiac Allograft Arteriopathy

By Suzuki J.   Isobe M.   Morishita R.   Aoki M.   Yamazaki S.   Kaneda Y.   Sawa Y.   Matsuda H.   Ogihara T.   Horie S.   Okubo Y.   Sekiguchi M.  

Transplantation Proceedings, Vol. 30, Iss. 1, 1998-02 ,pp. : 89-90

Elsevier

Access to resources Recommend Favorite

Allograft acceptance and rejection, mediated by a liver suppressor factor, LSF-1, purified from serum of liver transplanted rats

By Edwards-Smith C.   Goto S.   Lord R.   Shimizu Y.   Vari F.   Kamada N.  

Transplant Immunology, Vol. 4, Iss. 4, 1996-12 ,pp. : 287-292

Elsevier

Access to resources Recommend Favorite